Helicobacter pylori strain N6

Helicobacter pylori strain N6 is a Gram-negative, microaerophilic bacterium characterized by its spirilla shape and presence of flagella, allowing for mobility in its host-associated habitat. This bacterium has a single replicon and is surrounded by two membranes, typical of its Gram-negative classification. Optimal growth occurs at a temperature of 37°C, placing it within the mesophilic temperature range. H. pylori strain N6 is known to inhabit various hosts, including Homo sapiens (humans), Gallus gallus (domestic chickens), and other avian and mammalian species, as well as amoebae. The strain is associated with several significant health effects in humans, including chronic gastric inflammation, gastric ulcers, and multiple forms of gastric cancer, such as gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. It is also implicated in conditions like gastroesophageal reflux disease (GERD) and functional dyspepsia. The pathogenicity of H. pylori strain N6 in humans highlights its role in gastrointestinal diseases, specifically its contribution to peptic ulcer disease and gastric tumors. The bacterium can lead to asymptomatic mucosal inflammatory responses, chronic gastritis, and various forms of dysplasia. Given its association with serious health conditions, understanding its biological and ecological dynamics is crucial for developing preventive and therapeutic strategies against H. pylori-related diseases. The strain's ability to thrive in diverse environments underscores its ecological flexibility and the importance of host interactions in its lifecycle.